İlknur,Karakus Şeyma,Gültekin Serap,Özçınar Beyza,Özmen Vahit,İğci Abdullah,Müslümanoğlu Mahmut Ebudeccane,Dinçcag Sait Ahmet Der 18. SIS-Weltkongress zur Brustgesundheit 16.-19. September 2014 Orlando, USA 3-Axillary Lymph Node Ratio Is An Independent Prognostic Factor In Breast Cancer Üçüncü Muhammed Zübeyr, Karakuş Şeyma, Tükenmez Mustafa, Kaya Serdar, Yüksel Sercan, Özmen Vahit, Müslümanoğlu Mahmut Ebudeccane, Dinççağ Ahmet Sait, İğci Abdullah, Özçınar Beyza, Cabıoğlu Neslihan Der 18. SIS-Weltkongress zum Thema Brustgesundheit am 1. September -19.2014 Orlando, USA Dr. Muhammed Zübeyr Üçüncü ist Facharzt für Allgemeine Chirurgie und außerordentlicher Professor für Chirurgie mit einem Abschluss von der Medizinischen Fakultät der Universität Istanbul. Dr. Üçüncü verfügt über umfangreiche Erfahrung in der Behandlung von akuter biliärer Pankreatitis, Endoskopie, Trauma- und Notfallchirurgie, Fettleibigkeit und Brustgesundheit. Er hat mehrere Artikel in medizinischen Fachzeitschriften veröffentlicht und auf internationalen Konferenzen präsentiert.
Mehr lesenİlknur,Karakus Şeyma,Gültekin Serap,Özçınar Beyza,Özmen Vahit,İğci Abdullah,Müslümanoğlu Mahmut Ebudeccane,Dinçcag Sait Ahmet Der 18. SIS-Weltkongress zur Brustgesundheit 16.-19. September 2014 Orlando, USA 3-Axillary Lymph Node Ratio Is An Independent Prognostic Factor In Breast Cancer Üçüncü Muhammed Zübeyr, Karakuş Şeyma, Tükenmez Mustafa, Kaya Serdar, Yüksel Sercan, Özmen Vahit, Müslümanoğlu Mahmut Ebudeccane, Dinççağ Ahmet Sait, İğci Abdullah, Özçınar Beyza, Cabıoğlu Neslihan Der 18. SIS-Weltkongress zum Thema Brustgesundheit am 1. September -19.2014 Orlando, USA Dr. Muhammed Zübeyr Üçüncü ist Facharzt für Allgemeine Chirurgie und außerordentlicher Professor für Chirurgie mit einem Abschluss von der Medizinischen Fakultät der Universität Istanbul. Dr. Üçüncü verfügt über umfangreiche Erfahrung in der Behandlung von akuter biliärer Pankreatitis, Endoskopie, Trauma- und Notfallchirurgie, Fettleibigkeit und Brustgesundheit. Er hat mehrere Artikel in medizinischen Fachzeitschriften veröffentlicht und auf internationalen Konferenzen präsentiert.
Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:
Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:
Prof. M.D. Yusuf Serdar Sakin was born in Nevşehir in 1978. After completing his primary and secondary education in Ankara, he graduated from the Faculty of Medicine at Gülhane Military Medical Academy in 2002.
Following his graduation, he served in Gole/Ardahan for two years. He started his internal medicine training at the Department of Internal Medicine, Gülhane Faculty of Medicine.
After completing his training, he worked as an internal medicine specialist in Ankara. A year later, he began additional training in the Department of Gastroenterology at Gülhane Faculty of Medicine and completed his training in 2014.
After graduation, Yusuf Serdar Sakin continued to work in the same department. He also received advanced endoscopy and Motility training at AMC Center in the Netherlands in 2017.
After obtaining the title of Associate Professor in 2017, he became a Professor in 2023.
He currently provides medical services to patients at Koru Ankara Hospital. His areas of medical interest include:
-Endoscopic retrograde cholangiopancreatography (ERCP)
-Push enteroscopy
-Endoscopic mucosal resection
-High-resolution manometry
-pH/pH-impedance metry analysis
-Advanced endoscopic procedures (stenting, dilation, etc.)
-Gastrointestinal motility disorders
-Gastroesophageal reflux disease
-Inflammatory bowel diseases
-Advanced endoscopic procedures and pancreatitis.
Prof. M.D. Yusuf Serdar Sakin was born in Nevşehir in 1978. After completing his primary and secondary education in Ankara, he graduated from the Faculty of Medicine at Gülhane Military Medical Academy in 2002.
Following his graduation, he served in Gole/Ardahan for two years. He started his internal medicine training at the Department of Internal Medicine, Gülhane Faculty of Medicine.
After completing his training, he worked as an internal medicine specialist in Ankara. A year later, he began additional training in the Department of Gastroenterology at Gülhane Faculty of Medicine and completed his training in 2014.
After graduation, Yusuf Serdar Sakin continued to work in the same department. He also received advanced endoscopy and Motility training at AMC Center in the Netherlands in 2017.
After obtaining the title of Associate Professor in 2017, he became a Professor in 2023.
He currently provides medical services to patients at Koru Ankara Hospital. His areas of medical interest include:
-Endoscopic retrograde cholangiopancreatography (ERCP)
-Push enteroscopy
-Endoscopic mucosal resection
-High-resolution manometry
-pH/pH-impedance metry analysis
-Advanced endoscopic procedures (stenting, dilation, etc.)
-Gastrointestinal motility disorders
-Gastroesophageal reflux disease
-Inflammatory bowel diseases
-Advanced endoscopic procedures and pancreatitis.